BioSpace News Archive

Drug Development

Verona Pharma Reports Patient Enrollment Progressing Ahead of Schedule in Ongoing Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment

Top-line data from the study now expected in mid-2018.

November 7, 2017
·
8 min read
Genetown

MilliporeSigma Release: Parteck M DPI from MilliporeSigma – A New Carrier for Dry Powder Inhalation Applications

Parteck M DPI is a new grade of mannitol from MilliporeSigma that improves flow and release characteristics of APIs in drugs delivered via dry, inhaled powders.

November 7, 2017
·
1 min read
Business

Professor Heikki Joensuu Has Been Appointed Vice President of Therapy Area Oncology, R&D in Orion Corporation

Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher.

November 7, 2017
·
3 min read
AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017

AxoGen executives and surgeon thought leaders will discuss the company’s comprehensive platform for peripheral nerve repair and the emerging nerve repair market.

November 7, 2017
·
4 min read
Business

Curis Reports Third Quarter 2017 Financial Results

Management to host conference call today at 8:30 a.m. EST.

November 7, 2017
·
13 min read
Business

Cambrex Reports Third Quarter 2017 Financial Results

Net Revenue increased 13% to $112.6 million compared to $99.4 million in the same quarter last year.

November 7, 2017
·
16 min read
Business

ImmuCell Announces Completion of Construction of Nisin Production Facility

A Certificate of Occupancy for this facility was issued by the City of Portland, Maine on October 30, 2017.

November 7, 2017
·
6 min read
argenx Announces Results of Extraordinary Shareholders’ Meeting 2017

All proposed resolutions on the agenda for this extraordinary shareholders’ meeting were approved.

November 7, 2017
·
3 min read
Business

pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution

Revenue for the first fiscal quarter ended September 30, 2017 totaled $385,000 compared to $277,000 for the prior year quarter.

November 7, 2017
·
8 min read
Business

Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th

A conference call and webcast will follow at 4:30 p.m. EST (1:30 p.m. PST).

November 7, 2017
·
2 min read